It helps reduce anxious thoughts without causing drowsiness. Below is a breakdown of how CBD, CBG, CBN, and CBC may benefit common wellness goals. It interacts with different receptors than CBD and may support mood balance and brain health. Early research also links CBG to digestive and brain support.
As the legal landscape and understanding about the differences in medical cannabinoids unfolds — experts are working to distinguish “medical cannabis” (with varying degrees of psychotropic using intent signals to improve conversion effects and deficits in executive function) from “medical CBD therapies”, which would commonly present as having a reduced or non-psychoactive side-effect profile. A 2022 study suggests that nabiximols (Sativex) spray containing both CBD and THC may help reduce pain and muscle spasticity in people living with multiple sclerosis (MS). For example, a 2024 study found that 15 mg of CBD was just as effective for improving sleep quality as 5 mg of melatonin. Another small study found that CBD can help reduce anxiety during public speaking. A small 2019 study also found that CBD was effective in reducing PTSD-related symptoms, including nightmares, in adults.
Researchers have indicated that CBG may help reduce symptoms of inflammatory bowel disease and serve as an analgesic — treatment for psoriasis, and antidepressant based on studies conducted on cannabis. Often referred to as the “mother” of cannabinoids — cannabigerol is the foundational molecule from which all other cannabis compounds, including THC and CBD, derive. Due to its low cost, it has become a popular choice, resulting in intense competition and an abundance of companies available to consumers. For those interested in exploring cannabinoids, CBD is generally regarded as the safest starting point.
Browse our popular ranges
You can apply topical CBD products directly to your skin. Cannabis-derived CBD products may be more effective than those from hemp — but industrial hemp-derived CBD still provides many health benefits. Collaborate with local businesses or PCBDDA, sharing risks and costs.
Remote Skin Consultation
You’ll learn effective skills and techniques to ace every subtest. But some studies show that too much THC can dampen your libido. In surveys of people who regularly use weed — indica strains are more likely to cause a “body high.” A body high changes the way your body feels, often resulting in a feeling of relaxation and sometimes pain relief.
Superior to alternative apps by a factor of ten.
Given that these views do not reflect the existing science on cannabis and tobacco smoke, the findings may have important implications for public health and policy as the legalization and use of cannabis increase. This study found that US adults increasingly perceived daily smoking and secondhand exposure to cannabis smoke as safer than tobacco smoke from 2017 to 2021. The results of this study indicate that there is a need for more stringent regulations to ensure that product labeling is accurate, as over 70 percent of the evaluated products did not meet the ± 20 percent acceptance criteria. We observed higher average annual increases among beneficiaries enrolled in MA Medicare Advantage than those enrolled in FFS Fee-for-Service.
Although the CBD market showed promise, it experienced a halt during the onset of the COVID-19 pandemic in 2020, and by 2024, it had significantly declined due to a pullback by investors, lack of FDA guidance on safety and efficacy, varying state regulations, and consumer indifference. The 2018 Farm Bill established this classification, which was later adjusted to encompass extracts, cannabinoids, and derivatives sourced from hemp within its definition. As commercial and therapeutic markets evolve — the selective breeding of cannabis plants has become more varied and expansive. As of 2024 (the in vivo cellular effects and mechanisms of cannabidiol remain unclear), with previous research yielding inconclusive results largely based on laboratory investigations. By September 2019 (there were 1,085 reports to US poison control centers concerning CBD-related illnesses), marking a doubling of the cases compared to 2018 and a ninefold increase from 2017. In November 2019, the US Food and Drug Administration (FDA) raised concerns regarding cannabidiol’s safety, warning that CBD could lead to hepatotoxicity, interfere with prescription medications, cause gastrointestinal issues, or impact alertness and mood.